(Q53564533)

15 May 2018

title

Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test. (English)

1 reference

15 May 2018

1 reference

1 reference

Shiho Takashima

1

1 reference

15 May 2018

Jun Kato

2

1 reference

15 May 2018

Sakiko Hiraoka

3

1 reference

15 May 2018

Asuka Nakarai

4

1 reference

15 May 2018

Daisuke Takei

5

1 reference

15 May 2018

Toshihiro Inokuchi

6

1 reference

15 May 2018

Yuusaku Sugihara

7

1 reference

15 May 2018

Masahiro Takahara

8

1 reference

15 May 2018

Keita Harada

9

1 reference

15 May 2018

Hiroyuki Okada

10

1 reference

15 May 2018

Takehiro Tanaka

11

1 reference

15 May 2018

Kazuhide Yamamoto

12

1 reference

15 May 2018

language of work or name

English

0 references

publication date

31 March 2015

1 reference

15 May 2018

The American Journal of Gastroenterology

published in

1 reference

15 May 2018

volume

110

1 reference

15 May 2018

issue

6

1 reference

15 May 2018

page(s)

873-880

1 reference

15 May 2018

Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.66

Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.66

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.66

Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.66

Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.66

Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.66

Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.66

Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.66

Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.66

A reproducible grading scale for histological assessment of inflammation in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.66

Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.66

Importance of mucosal healing in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.66

Immunochemical fecal occult blood test is not suitable for diagnosis of hemorrhoids

21 January 2018

1 reference

12 December 2020

A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis

1 reference

12 December 2020

Hemorrhoids detected at colonoscopy: an infrequent cause of false-positive fecal immunochemical test results

1 reference

12 December 2020

The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis

1 reference

12 December 2020

Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort

1 reference

12 December 2020

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study

1 reference

12 December 2020

Therapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease: a prospective study

1 reference

12 December 2020

Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation

1 reference

12 December 2020

Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis

1 reference

12 December 2020

Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience

1 reference

12 December 2020

Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study

1 reference

12 December 2020

Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy

1 reference

12 December 2020

Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJG.2015.66

1 reference

15 May 2018

1 reference

15 May 2018